{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,6]],"date-time":"2024-06-06T00:35:48Z","timestamp":1717634148124},"reference-count":13,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,6,5]]},"DOI":"10.7759\/cureus.61724","type":"journal-article","created":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T13:01:28Z","timestamp":1717592488000},"source":"Crossref","is-referenced-by-count":0,"title":["Direct-Acting Antiviral Treatment for Acute Hepatitis C in Japanese Patients: Clinical Course and Outcomes"],"prefix":"10.7759","author":[{"given":"Hiroshi","family":"Okano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsumi","family":"Mukai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Nishimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.7326\/M16-2575","article-title":"Oral direct-acting agent therapy for hepatitis C virus infection: a systematic review","volume":"166","author":"Falade-Nwulia O","year":"2017","unstructured":"Falade-Nwulia O, Suarez-Cuervo C, Nelson DR, Fried MW, Segal JB, Sulkowski MS. Oral direct-acting agent therapy for hepatitis C virus infection: a systematic review. Ann Intern Med. 2017, 166:637-48. 10.7326\/M16-2575","journal-title":"Ann Intern Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29408","article-title":"Impact of sustained virologic response with direct-acting antiviral treatment on mortality in patients with advanced liver disease","volume":"69","author":"Backus LI","year":"2019","unstructured":"Backus LI, Belperio PS, Shahoumian TA, Mole LA. Impact of sustained virologic response with direct-acting antiviral treatment on mortality in patients with advanced liver disease. Hepatology. 2019, 69:487-97. 10.1002\/hep.29408","journal-title":"Hepatology"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)61116-2","article-title":"Acute hepatitis C","volume":"372","author":"Maheshwari A","year":"2008","unstructured":"Maheshwari A, Ray S, Thuluvath PJ. Acute hepatitis C. Lancet. 2008, 372:321-32. 10.1016\/S0140-6736(08)61116-2","journal-title":"Lancet"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2003.50019","article-title":"Spontaneous viral clearance in patients with acute hepatitis C can be predicted by repeated measurements of serum viral load","volume":"37","author":"Hofer H","year":"2003","unstructured":"Hofer H, Watkins-Riedel T, Janata O, et al.. Spontaneous viral clearance in patients with acute hepatitis C can be predicted by repeated measurements of serum viral load. Hepatology. 2003, 37:60-4. 10.1053\/jhep.2003.50019","journal-title":"Hepatology"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2018.03.026","article-title":"EASL Recommendations on Treatment of Hepatitis C 2018","volume":"69","year":"2018","unstructured":"EASL Recommendations on Treatment of Hepatitis C 2018. J Hepatol. 2018, 69.461-511. 10.1016\/j.jhep.2018.03.026","journal-title":"J Hepatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31060","article-title":"Hepatitis C Guidance 2019 Update: American Association for the Study of Liver Diseases-Infectious Diseases Society of America Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection","volume":"71","author":"Ghany MG","year":"2020","unstructured":"Ghany MG, Morgan TR. Hepatitis C Guidance 2019 Update: American Association for the Study of Liver Diseases-Infectious Diseases Society of America Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection. Hepatology. 2020, 71:686-721. 10.1002\/hep.31060","journal-title":"Hepatology"},{"key":"ref7","unstructured":"Suzuka General Hospital, Disclosure of Clinical Trial Information. (2024). Accessed. May, 26: http:\/\/www.miekosei.or.jp\/2_sch\/gan\/chiken.html."},{"key":"ref8","doi-asserted-by":"crossref","DOI":"10.26502\/acmcr.96550390","article-title":"Acute hepatitis C virus infections in spouses: the utility of a genetic analysis of the hepatitis C virus hypervariable region sequence for identifying the infectious source","volume":"5","author":"Okano H","year":"2021","unstructured":"Okano H, Murakami M, Asakawa H, et al.. Acute hepatitis C virus infections in spouses: the utility of a genetic analysis of the hepatitis C virus hypervariable region sequence for identifying the infectious source. Arch Clin Med Case Rep. 2021, 5:537-48.","journal-title":"Arch Clin Med Case Rep"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s12328-010-0171-z","article-title":"A case of severe acute hepatitis C and delayed antibody production due to rituximab therapy","volume":"3","author":"Hiura M","year":"2010","unstructured":"Hiura M, Onizuka R, Narita R, Abe S, Tabaru A, Harada M. A case of severe acute hepatitis C and delayed antibody production due to rituximab therapy. Clin J Gastroenterol. 2010, 3:254-8. 10.1007\/s12328-010-0171-z","journal-title":"Clin J Gastroenterol"},{"key":"ref10","article-title":"Diagnosis and management of hepatitis C","volume":"91","author":"Wilkins T","year":"2015","unstructured":"Wilkins T, Akhtar M, Gititu E, Jalluri C, Ramirez J. Diagnosis and management of hepatitis C. Am Fam Physician. 2015, 91:835-42.","journal-title":"Am Fam Physician"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1055\/s-0043-120925","article-title":"Acute liver failure as a rare case of a frequent disease (Article in German)","volume":"56","author":"Thiel AM","year":"2018","unstructured":"Thiel AM, Rissland J, Lammert F, Casper M. Acute liver failure as a rare case of a frequent disease (Article in German). Z Gastroenterol. 2018, 56:255-8. 10.1055\/s-0043-120925","journal-title":"Z Gastroenterol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3350\/cmh.2022.0349","article-title":"Acute hepatitis C virus infection: clinical update and remaining challenges","volume":"29","author":"Liu CH","year":"2023","unstructured":"Liu CH, Kao JH. Acute hepatitis C virus infection: clinical update and remaining challenges. Clin Mol Hepatol. 2023, 29:623-42. 10.3350\/cmh.2022.0349","journal-title":"Clin Mol Hepatol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2016.07.012","article-title":"HCV epidemiology in high-risk groups and the risk of reinfection","volume":"65","author":"Midgard H","year":"2016","unstructured":"Midgard H, Weir A, Palmateer N, Lo Re V 3rd, Pineda JA, Mac\u00edas J, Dalgard O. HCV epidemiology in high-risk groups and the risk of reinfection. J Hepatol. 2016, 65:S33-45. 10.1016\/j.jhep.2016.07.012","journal-title":"J Hepatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/259643-direct-acting-antiviral-treatment-for-acute-hepatitis-c-in-japanese-patients-clinical-course-and-outcomes","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T13:01:33Z","timestamp":1717592493000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/259643-direct-acting-antiviral-treatment-for-acute-hepatitis-c-in-japanese-patients-clinical-course-and-outcomes"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,5]]},"references-count":13,"URL":"https:\/\/doi.org\/10.7759\/cureus.61724","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6,5]]}}}